Tune into this podcast, where New Hope Network and Natural Products Insider dig into the most relevant topics related to hemp and CBD in order to cultivate a responsible industry, from seed to shelf.

April 1, 2020

1 Min Read
HC_podcast_March_feature_1200x400 (1).jpg

In our third Hemp Collective podcast episode, we talk to Claudia Lewis, Venable LLP co-chair FDA Group, and Michael Flemmens, VP science, SōRSE Technology, exploring the regulatory requirements and manufacturing practices required for producing the highest quality hemp CBD products. We discuss the priorities of FDA today, and we explore some of the nuances of understanding your customer, assuring you can deliver on your brand's quality promise as a manufacturer or with your co-manufacturers.

HC_podcast-feature-image-3.jpg

Become a hemp industry expert. Tune in today and stay tuned monthly!

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like